Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_001134225.2(INPP4A):c.673T>C(p.Phe225Leu) variant causes a missense, splice region change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
INPP4A (HGNC:6074): (inositol polyphosphate-4-phosphatase type I A) This gene encodes an Mg++ independent enzyme that hydrolyzes the 4-position phosphate from the inositol ring of phosphatidylinositol 3,4-bisphosphate, inositol 1,3,4-trisphosphate, and inositol 3,4-bisphosphate. Multiple transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Aug 2008]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.673T>C (p.F225L) alteration is located in exon 10 (coding exon 8) of the INPP4A gene. This alteration results from a T to C substitution at nucleotide position 673, causing the phenylalanine (F) at amino acid position 225 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Gain of catalytic residue at F225 (P = 0.0785);Gain of catalytic residue at F225 (P = 0.0785);Gain of catalytic residue at F225 (P = 0.0785);Gain of catalytic residue at F225 (P = 0.0785);Gain of catalytic residue at F225 (P = 0.0785);